Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05431309

Role of Screening With Coronary Computed Tomography Angiography in Primary Prevention of Coronary Heart Disease

Role of Screening With Coronary Computed Tomography Angiography in Primary Prevention of Coronary Heart Disease: a Community-based, Prospective Randomised Controlled Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15,000 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
40 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy will be superior to traditional CHD prevention strategy, in reducing the future risk of CHD which included myocardial infarction, angina, cardiac death, and an emergency/urgent coronary revascularisation procedure, in a community population aged 40 to 69 years with cardiovascular risk factors but no history of cardiovascular disease.

Detailed description

Recent studies found that the incidence of CAD, screening with CCTA, in the general population is as high as 42%\~49%. However, the effectiveness of CCTA screening in the primary prevention of CHD is unclear. The investigators designed a randomized controlled, open-label, pragmatic study to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy will be superior to traditional CHD prevention strategy. Community volunteers aged 40 to 69 years who provide consent, and are eligible (with cardiovascular risk factors but no history of cardiovascular disease), will be randomized 1:1 to receive individualized primary prevention programs for CHD, including statin recommendation, based on CCTA results or traditional risk assessment results using the Chinese guideline on the primary prevention of cardiovascular diseases-recommended strategy. All subjects will be followed for 5 years, but until the target primary endpoint event is met. The primary composite outcome was the first occurrence of CHD, which included myocardial infarction, angina, cardiac death, and an emergency/urgent coronary revascularisation procedure. In order to prepare the study with high quality, the investigators will performed a pilot study prior to the initiation of patient recruitment for the main study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCoronary Computed Tomography AngiographyIntervention strategies were selected according to CCTA results
OTHERStandard TreatmentTraditional cardiovascular disease prevention strategy based on Chinese guideline

Timeline

Start date
2022-07-01
Primary completion
2028-11-30
Completion
2028-11-30
First posted
2022-06-24
Last updated
2022-07-07

Source: ClinicalTrials.gov record NCT05431309. Inclusion in this directory is not an endorsement.